Back to Search
MICAELA WIRE, PHD
PHD
Clinical Child & Adolescent Psychologist
NPI: 1902155195Individual
Specialties, Licenses & Credentials
Clinical Child & Adolescent PsychologistPrimary
Psychologist — Clinical Child & Adolescent
Code: 103TC2200X
021591(NY)
Research & Publications (19)
Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.
PMID 19667283·Antimicrob Agents Chemother·2009
3-trial
Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance.
PMID 19515730·J Antimicrob Chemother·2009
2-rct
Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
PMID 19446149·Clin Ther·2009
4-observational
Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
PMID 18576901·Pharmacotherapy·2008
3-trial
Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.
PMID 17088488·Antimicrob Agents Chemother·2007
3-trial
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
PMID 17517848·Antimicrob Agents Chemother·2007
3-trial
Pharmacokinetic and safety evaluation of high-dose combinations of fosamprenavir and ritonavir.
PMID 16495253·Antimicrob Agents Chemother·2006
3-trial
Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug.
PMID 16485915·Clin Pharmacokinet·2006
6-review
Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APV.
PMID 16569890·Antimicrob Agents Chemother·2006
2-rct
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.
PMID 16639341·J Acquir Immune Defic Syndr·2006
8-other
Interaction between fosamprenavir, with and without ritonavir, and nevirapine in human immunodeficiency virus-infected subjects.
PMID 16940117·Antimicrob Agents Chemother·2006
3-trial
Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
PMID 15616339·Antimicrob Agents Chemother·2005
3-trial
Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.
PMID 15460171·Pharmacotherapy·2004
3-trial
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients.
PMID 15356829·Clin Infect Dis·2004
3-trial
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
PMID 14693528·Antimicrob Agents Chemother·2004
3-trial
Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers.
PMID 15060437·AIDS·2004
3-trial
Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects.
PMID 12654667·Antimicrob Agents Chemother·2003
3-trial
Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.
PMID 12183255·Antimicrob Agents Chemother·2002
3-trial
Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.
PMID 12203175·Clin Infect Dis·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 135 W 50TH ST
NEW YORK, NY 10020 - Phone
- (212) 582-9100
Quick Facts
- NPI
- 1902155195
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile